OR WAIT null SECS
January 07, 2011
During the past few years, we've seen a growing interest in direct oral application products, evidenced by the large amount of products already available on the market.
Iain Moore explains what progress has been made so far regarding EU plans to regulate excipients.
Biologics are large molecular weight molecules primarily formulated for parenteral administration; however, there are some smaller biomolecules that have been formulated for oral use.
Excipients should be regulated to manage risk. Although, excipients are an integral part of a finished pharmaceutical product, the issue of regulation is complex.
January 02, 2011
Contract manufacturers strengthen their toolboxes and partnerships as they navigate the changing drug-development model.
January 01, 2011
Excipient purity is critical in all applications of drug formulation. Typically, the more sensitive or reactive an API, the more critical excipient purity becomes.
December 02, 2010
Approaches in cyclization, palladium-catalyzed cross couplings, fluorination, and natural product synthesis help to optimize routes for select drugs.
IPEC extends its reach to Brazil and Argentina in an effort to harmonize excipient best practices.
November 02, 2010
Abuse-deterrent combination drugs represent a niche area in formulation development.
Industrial and academic partnerships forge new territory in solid-state chemistry.